Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with neoadjuvant therapy in large HER2-negative breast cancer
2008-003006-34Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- May 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bevacizumab in breast cancer (4 arms), sponsored by Oslo University Hospital. Primary endpoint: Clinical objective response. Started May 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-003006-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003006-34.